1832 Asset Management L.P. Novartis Ag Transaction History

1832 Asset Management L.P.

  • $51.1 Billion
  • Q4 2024

A detailed history of 1832 Asset Management L.P. transactions in Novartis Ag stock. As of the latest transaction made, 1832 Asset Management L.P. holds 6,144 shares of NVS stock, worth $684,933. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,144
Previous 6,356 3.34%
Holding current value
$684,933
Previous $731,000 18.33%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$96.78 - $117.18 $20,517 - $24,842
-212 Reduced 3.34%
6,144 $597,000
Q3 2024

Nov 13, 2024
BUY
$106.13 - $120.89 $21,226 - $24,178
200 Added 3.25%
6,356 $731,000
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $40,638 - $47,135
-439 Reduced 6.66%
6,156 $655,000
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $286,191 - $325,843
-3,004 Reduced 31.29%
6,595 $637,000
Q4 2023

Feb 13, 2024
BUY
$92.27 - $101.54 $284,283 - $312,844
3,081 Added 47.27%
9,599 $969,000
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $617,450 - $685,237
6,518 New
6,518 $663,000
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $416,340 - $472,095
-4,500 Reduced 40.32%
6,662 $672,000
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $34,172 - $39,629
427 Added 3.98%
11,162 $1.03 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $87,713 - $107,415
-1,161 Reduced 9.76%
10,735 $973,000
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $27,307 - $31,937
-366 Reduced 2.98%
11,896 $904,000
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $72,951 - $84,937
-906 Reduced 6.88%
12,262 $1.04 Million
Q1 2022

May 16, 2022
BUY
$80.11 - $90.62 $15,140 - $17,127
189 Added 1.46%
13,168 $1.14 Million
Q4 2021

Feb 15, 2022
BUY
$79.7 - $88.13 $24,946 - $27,584
313 Added 2.47%
12,979 $1.15 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $59,290 - $68,976
-725 Reduced 5.41%
12,666 $1.04 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $230,318 - $254,393
-2,702 Reduced 16.79%
13,391 $1.22 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $60,454 - $71,292
-724 Reduced 4.31%
16,093 $1.31 Million
Q4 2020

Feb 16, 2021
BUY
$78.07 - $94.43 $98,914 - $119,642
1,267 Added 8.15%
16,817 $1.5 Million
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $148,837 - $164,892
1,812 Added 13.19%
15,550 $1.26 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $4.16 Million - $4.68 Million
-51,368 Reduced 78.9%
13,738 $1.1 Million
Q1 2020

May 26, 2020
BUY
$70.67 - $99.01 $4.23 Million - $5.92 Million
59,796 Added 1126.1%
65,106 $5.26 Million
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $423,525 - $593,366
-5,993 Reduced 53.02%
5,310 $441,000
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $545,322 - $616,567
6,465 Added 133.63%
11,303 $973,000
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $36,097 - $39,777
-422 Reduced 8.02%
4,838 $422,000
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $36,342 - $44,729
-482 Reduced 8.39%
5,260 $480,000
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $19,884 - $22,743
264 Added 4.82%
5,742 $549,000
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $15,394 - $17,142
-209 Reduced 3.68%
5,478 $471,000
Q3 2018

Nov 14, 2018
BUY
$66.94 - $77.43 $52,280 - $60,472
781 Added 15.92%
5,687 $491,000
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $20,057 - $22,668
309 Added 6.72%
4,906 $396,000
Q1 2018

May 15, 2018
SELL
$70.39 - $84.15 $81,159 - $97,024
-1,153 Reduced 20.05%
4,597 $371,000
Q4 2017

Feb 14, 2018
SELL
$72.33 - $77.64 $1.8 Million - $1.93 Million
-24,893 Reduced 81.24%
5,750 $481,000
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $2.27 Million - $2.37 Million
30,643
30,643 $2.63 Million

Others Institutions Holding NVS

# of Institutions
1,487
Shares Held
131M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $240B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email